| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | Director | Common Stock | 10,046 | $679,125 | $67.60 | 13 Oct 2025 | Direct |
| Verona Pharma plc | Chief Financial Officer | Ordinary Shares | 0 | $0 | $106.71 | 07 Oct 2025 | Direct |
| Verona Pharma plc | Chief Financial Officer | Restricted Share Units | 445,536 | 07 Jul 2025 | Direct | ||
| Verona Pharma plc | Chief Financial Officer | Restricted Stock Units | 389,792 | 01 Aug 2025 | Direct | ||
| ALSP Orchid Acquisition Corp I | Director | No securities are beneficially owned | 0 | 18 Nov 2021 | Direct | ||
| Verona Pharma plc | Chief Financial Officer | Restricted Share Unit | 0 | 07 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 13 Oct 2025 | 1 | $0 | 4 | Director | 14 Oct 2025, 16:23 |
| SLNO | SOLENO THERAPEUTICS INC | 13 Oct 2025 | 0 | $0 | 3 | Director | 14 Oct 2025, 16:19 |
| VRNA | Verona Pharma plc | 07 Oct 2025 | 8 | $0 | 4 | Chief Financial Officer | 08 Oct 2025, 16:42 |
| VRNA | Verona Pharma plc | 29 Aug 2025 | 1 | $0 | 4 | Chief Financial Officer | 03 Sep 2025, 16:30 |
| VRNA | Verona Pharma plc | 01 Aug 2025 | 4 | -$2,745,877 | 4 | Chief Financial Officer | 05 Aug 2025, 20:28 |
| VRNA | Verona Pharma plc | 07 Jul 2025 | 4 | -$1,033,378 | 4 | Chief Financial Officer | 09 Jul 2025, 18:41 |
| VRNA | Verona Pharma plc | 11 Jun 2025 | 1 | -$4,560,360 | 4 | Chief Financial Officer | 13 Jun 2025, 16:31 |
| VRNA | Verona Pharma plc | 27 May 2025 | 3 | -$3,733,944 | 4 | Chief Financial Officer | 29 May 2025, 16:16 |
| VRNA | Verona Pharma plc | 01 May 2025 | 5 | -$5,311,479 | 4 | Chief Financial Officer | 05 May 2025, 16:31 |
| VRNA | Verona Pharma plc | 01 Feb 2025 | 2 | -$1,195,335 | 4 | Chief Financial Officer | 04 Feb 2025, 16:30 |
| VRNA | Verona Pharma plc | 04 Dec 2024 | 3 | -$4,415,452 | 4 | Chief Financial Officer | 06 Dec 2024, 17:50 |
| VRNA | Verona Pharma plc | 27 Nov 2024 | 3 | -$566,822 | 4 | Chief Financial Officer | 02 Dec 2024, 19:20 |
| VRNA | Verona Pharma plc | 25 Nov 2024 | 2 | -$12,000 | 4 | Chief Financial Officer | 26 Nov 2024, 18:36 |
| VRNA | Verona Pharma plc | 11 Nov 2024 | 1 | -$12,000 | 4 | Chief Financial Officer | 13 Nov 2024, 16:57 |
| VRNA | Verona Pharma plc | 01 Nov 2024 | 2 | -$568,387 | 4 | Chief Financial Officer | 05 Nov 2024, 17:40 |
| VRNA | Verona Pharma plc | 30 Oct 2024 | 3 | -$1,043,132 | 4 | Chief Financial Officer | 01 Nov 2024, 19:14 |
| VRNA | Verona Pharma plc | 24 Oct 2024 | 2 | -$632,761 | 4 | Chief Financial Officer | 25 Oct 2024, 19:55 |
| VRNA | Verona Pharma plc | 18 Oct 2024 | 3 | -$2,303,773 | 4 | Chief Financial Officer | 22 Oct 2024, 20:45 |
| VRNA | Verona Pharma plc | 11 Sep 2024 | 1 | -$2,254,080 | 4 | Chief Financial Officer | 13 Sep 2024, 16:15 |
| VRNA | Verona Pharma plc | 12 Aug 2024 | 3 | -$1,280,548 | 4 | Chief Financial Officer | 14 Aug 2024, 16:15 |
| VRNA | Verona Pharma plc | 07 Aug 2024 | 5 | -$811,433 | 4 | Chief Financial Officer | 01 May 2025, 20:55 |
| VRNA | Verona Pharma plc | 07 Aug 2024 | 2 | -$824,776 | 4 | Chief Financial Officer | 09 Aug 2024, 19:11 |
| VRNA | Verona Pharma plc | 01 Aug 2024 | 1 | -$250,801 | 4 | Chief Financial Officer | 05 Aug 2024, 21:30 |
| VRNA | Verona Pharma plc | 01 May 2024 | 1 | -$171,005 | 4 | Chief Financial Officer | 03 May 2024, 19:23 |
| VRNA | Verona Pharma plc | 01 Feb 2024 | 1 | -$1,102,547 | 4 | Chief Financial Officer | 05 Feb 2024, 18:09 |
| VRNA | Verona Pharma plc | 01 Nov 2023 | 1 | -$1,410,748 | 4 | Chief Financial Officer | 03 Nov 2023, 20:08 |
| VRNA | Verona Pharma plc | 20 Oct 2023 | 1 | $0 | 4 | Chief Financial Officer | 24 Oct 2023, 16:05 |
| VRNA | Verona Pharma plc | 03 Aug 2023 | 3 | -$693,897 | 4 | Chief Financial Officer | 07 Aug 2023, 21:17 |
| VRNA | Verona Pharma plc | 01 Aug 2023 | 2 | -$474,938 | 4 | Chief Financial Officer | 03 Aug 2023, 20:31 |
| VRNA | Verona Pharma plc | 01 May 2023 | 1 | -$1,173,395 | 4 | Chief Financial Officer | 03 May 2023, 19:48 |
| VRNA | Verona Pharma plc | 01 Feb 2023 | 1 | -$1,056,553 | 4 | Chief Financial Officer | 03 Feb 2023, 17:19 |
| VRNA | Verona Pharma plc | 20 Dec 2022 | 1 | -$1,269,060 | 4 | Chief Financial Officer | 21 Dec 2022, 15:05 |
| VRNA | Verona Pharma plc | 01 Nov 2022 | 2 | -$749,781 | 4 | Chief Financial Officer | 03 Nov 2022, 16:05 |
| VRNA | Verona Pharma plc | 26 Sep 2022 | 1 | $0 | 4 | Chief Financial Officer | 28 Sep 2022, 16:06 |
| VRNA | Verona Pharma plc | 09 Aug 2022 | 1 | -$1,050,000 | 4 | Chief Financial Officer | 11 Aug 2022, 21:45 |
| VRNA | Verona Pharma plc | 01 Aug 2022 | 2 | -$315,106 | 4 | Chief Financial Officer | 03 Aug 2022, 16:10 |
| VRNA | Verona Pharma plc | 03 May 2022 | 1 | -$6,201 | 4 | Chief Financial Officer | 05 May 2022, 19:18 |
| VRNA | Verona Pharma plc | 01 May 2022 | 1 | -$225,787 | 4 | Chief Financial Officer | 03 May 2022, 20:18 |
| VRNA | Verona Pharma plc | 01 Feb 2022 | 3 | -$131,673 | 4 | Chief Financial Officer | 03 Feb 2022, 16:54 |
| /report/000120919121065594-hahn-mark-w-2021-11-18 | ALSP Orchid Acquisition Corp I | 18 Nov 2021 | 0 | $0 | 3 | Director | 18 Nov 2021, 17:07 |
| VRNA | Verona Pharma plc | 01 Nov 2021 | 2 | -$297,824 | 4 | Chief Financial Officer | 03 Nov 2021, 19:51 |
| VRNA | Verona Pharma plc | 01 Aug 2021 | 2 | -$365,038 | 4 | Chief Financial Officer | 03 Aug 2021, 21:45 |